| dc.contributor.author | Kennedy, NA | en_US |
| dc.contributor.author | Heap, GA | en_US |
| dc.contributor.author | Green, HD | en_US |
| dc.contributor.author | Hamilton, B | en_US |
| dc.contributor.author | Bewshea, C | en_US |
| dc.contributor.author | Walker, GJ | en_US |
| dc.contributor.author | Thomas, A | en_US |
| dc.contributor.author | Nice, R | en_US |
| dc.contributor.author | Perry, MH | en_US |
| dc.contributor.author | Bouri, S | en_US |
| dc.contributor.author | Chanchlani, N | en_US |
| dc.contributor.author | Heerasing, NM | en_US |
| dc.contributor.author | Hendy, P | en_US |
| dc.contributor.author | Lin, S | en_US |
| dc.contributor.author | Gaya, DR | en_US |
| dc.contributor.author | Cummings, JRF | en_US |
| dc.contributor.author | Selinger, CP | en_US |
| dc.contributor.author | Lees, CW | en_US |
| dc.contributor.author | Hart, AL | en_US |
| dc.contributor.author | Parkes, M | en_US |
| dc.contributor.author | Sebastian, S | en_US |
| dc.contributor.author | Mansfield, JC | en_US |
| dc.contributor.author | Irving, PM | en_US |
| dc.contributor.author | Lindsay, J | en_US |
| dc.contributor.author | Russell, RK | en_US |
| dc.contributor.author | McDonald, TJ | en_US |
| dc.contributor.author | McGovern, D | en_US |
| dc.contributor.author | Goodhand, JR | en_US |
| dc.contributor.author | Ahmad, T | en_US |
| dc.contributor.author | Pharmaco, UKIBD | en_US |
| dc.date.accessioned | 2019-08-16T14:53:26Z | |
| dc.date.available | 2018-12-18 | en_US |
| dc.date.issued | 2019-05 | en_US |
| dc.identifier.issn | 2468-1253 | en_US |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/59186 | |
| dc.description.sponsorship | Guts UK, Crohn's and Colitis UK | en_US |
| dc.description.sponsorship | Cure Crohn's Colitis | en_US |
| dc.description.sponsorship | AbbVie | en_US |
| dc.description.sponsorship | Merck Sharp and Dohme | en_US |
| dc.description.sponsorship | Napp Pharmaceuticals | en_US |
| dc.description.sponsorship | Pfizer | en_US |
| dc.description.sponsorship | Celltrion | en_US |
| dc.format.extent | 341 - 353 | en_US |
| dc.language.iso | en | en_US |
| dc.relation.ispartof | LANCET GASTROENTEROLOGY & HEPATOLOGY | en_US |
| dc.title | Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study | en_US |
| dc.type | Article | |
| dc.identifier.doi | 10.1016/S2468-1253(19)30012-3 | en_US |
| pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000463786300020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.issue | 5 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 4 | en_US |
| rioxxterms.funder | Default funder | en_US |
| rioxxterms.identifier.project | Default project | en_US |
